Sutro Biopharma (STRO) Debt Ratio (2017 - 2023)

Sutro Biopharma has reported Debt Ratio for 7 years, with the latest figure at 0.01 in Q4 2023.

• Quarterly Debt Ratio fell 78.42% year-over-year to 0.01 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.01 (down 78.42% YoY) and the FY2023 annual result came in at 0.01, down 78.42% from the prior year.
• Debt Ratio fell to 0.01 in Q4 2023 per STRO's latest filing, from 0.02 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.16 in Q1 2020 and troughed at 0.01 in Q4 2023.
• A 5-year average of 0.06 and a median of 0.07 in 2019 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2020 and 2023: Debt Ratio soared 122.78% in 2020, then sank 78.42% in 2023.
• Over 5 years, Debt Ratio stood at 0.06 in 2019, then retreated by 1.39% to 0.06 in 2020, then grew by 18.11% to 0.07 in 2021, then tumbled by 45.64% to 0.04 in 2022, then plunged by 78.42% to 0.01 in 2023.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.01, 0.02, and 0.02 for Q4 2023, Q3 2023, and Q2 2023 respectively.